Advances in Cancer Imaging, Radiomics, and Radiotherapy

Dear Colleagues,

Cancer is an important health issue in the world. Imaging is important in cancer treatment. Cancer imaging involves X-ray, computed tomography (CT), magnetic resonance imaging (MRI), bone scan, Positron Emission Tomography (PET), endoscopy, ultrasound, pathology imaging, mammography, and so on. Imaging can be used in the pre-treatment of cancer, mid-treatment of cancer, and post-treatment of cancer. For the pre-treatment of cancer, imaging can be used for detection and staging. For mid-treatment of cancer, imaging can be used for adaptive treatment. For post-treatment of cancer, imaging can be used for follow-up or response assessment. The main treatments of cancer involve surgery, radiotherapy, and systemic therapy. Radiomics is a popular research method for classification and prognosis prediction in the field of cancer. Radiomics can be applied to almost all kinds of cancer imaging. The traditional methods of extracting radiomics features from imaging require the creation of regions of interest (ROIs). Clinical radiotherapy workflows involve contouring of imaging, which can serve as an ROI of radiomics. As a result, it is reasonable to combine radiomics and radiotherapy. This Special Issue on “Advances in Cancer Imaging, Radiomics, and Radiotherapy” aims to publish papers about Advances in Cancer Imaging, Radiomics, and Radiotherapy.

Dr. Yung-Shuo Kao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.